Joseph Loscalzo's most recent trade in Cypherpunk Technologies Inc. was a trade of 94,050 Restricted Stock Units done . Disclosure was reported to the exchange on Dec. 23, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Leap Therapeutics Inc | Joseph Loscalzo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 94,050 | 94,050 | - | - | Restricted Stock Units | |
| Leap Therapeutics Inc | Joseph Loscalzo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2025 | 74,700 | 74,700 | - | - | Restricted Stock Units | |
| Ionis Pharma Inc | Joseph Loscalzo | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 52.22 per share. | 31 Oct 2025 | 16,000 | 52,330 (0%) | 0% | 52.2 | 835,520 | Common Stock |
| Ionis Pharma Inc | Joseph Loscalzo | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 16,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharma Inc | Joseph Loscalzo | Director | Sale of securities on an exchange or to another person at price $ 75.10 per share. | 31 Oct 2025 | 16,000 | 36,330 (0%) | 0% | 75.1 | 1,201,669 | Common Stock |
| Ionis Pharma Inc | Joseph Loscalzo | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.42 per share. | 03 Sep 2025 | 16,000 | 52,330 (0%) | 0% | 24.4 | 390,720 | Common Stock |
| Ionis Pharma Inc | Joseph Loscalzo | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2025 | 16,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharma Inc | Joseph Loscalzo | Director | Sale of securities on an exchange or to another person at price $ 60.15 per share. | 03 Sep 2025 | 16,000 | 36,330 (0%) | 0% | 60.1 | 962,371 | Common Stock |
| Ionis Pharma Inc | Joseph Loscalzo | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2025 | 4,079 | 36,330 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | Joseph Loscalzo | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2025 | 4,079 | 5,220 | - | - | Restricted Stock Unit | |
| Ionis Pharma Inc | Joseph Loscalzo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 11,518 | 11,518 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharma Inc | Joseph Loscalzo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 5,220 | 9,299 | - | - | Restricted Stock Unit | |
| Ionis Pharma Inc | Joseph Loscalzo | Director | Sale of securities on an exchange or to another person at price $ 37.86 per share. | 12 Nov 2024 | 13,508 | 32,251 (0%) | 0% | 37.9 | 511,426 | Common Stock |
| Leap Therapeutics Inc | Joseph Loscalzo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2024 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Ionis Pharma Inc | Joseph Loscalzo | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2024 | 4,677 | 45,759 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | Joseph Loscalzo | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2024 | 4,677 | 4,079 | - | - | Restricted Stock Unit | |
| Ionis Pharma Inc | Joseph Loscalzo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 10,111 | 10,111 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharma Inc | Joseph Loscalzo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 4,079 | 8,756 | - | - | Restricted Stock Unit | |
| Leap Therapeutics Inc | Joseph Loscalzo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Leap Therapeutics Inc | Joseph Loscalzo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Aug 2023 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Ionis Pharma Inc | Joseph Loscalzo | Director, Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2023 | 5,333 | 41,082 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | Joseph Loscalzo | Director, Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2023 | 5,333 | 4,677 | - | - | Restricted Stock Unit | |
| Ionis Pharma Inc | Joseph Loscalzo | Director, Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2023 | 1,777 | 10,010 | - | - | Restricted Stock Unit | |
| Ionis Pharma Inc | Joseph Loscalzo | Director, Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2023 | 1,777 | 35,749 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | Joseph Loscalzo | Director, Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2023 | 10,321 | 10,321 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharma Inc | Joseph Loscalzo | Director, Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2023 | 4,677 | 11,787 | - | - | Restricted Stock Unit | |
| Leap Therapeutics Inc | Joseph Loscalzo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Ionis Pharma Inc | Joseph Loscalzo | Director, Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2022 | 5,333 | 9,775 | - | - | Restricted Stock Unit | |
| Ionis Pharma Inc | Joseph Loscalzo | Director, Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2022 | 5,333 | 31,307 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | Joseph Loscalzo | Director, Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2022 | 2,665 | 7,110 | - | - | Restricted Stock Unit | |
| Ionis Pharma Inc | Joseph Loscalzo | Director, Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2022 | 2,665 | 33,972 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | Joseph Loscalzo | Director, Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 12,000 | 12,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharma Inc | Joseph Loscalzo | Director, Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 5,333 | 15,108 | - | - | Restricted Stock Unit | |
| Leap Therapeutics Inc | Joseph Loscalzo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2022 | 55,000 | 55,000 | - | - | Stock Option (Right to Buy) | |
| Ionis Pharma Inc | Joseph Loscalzo | Director, Chairman of Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2021 | 5,333 | 22,641 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | Joseph Loscalzo | Director, Chairman of Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2021 | 5,333 | 13,108 | - | - | Restricted Stock Unit | |
| Ionis Pharma Inc | Joseph Loscalzo | Director, Chairman of Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2021 | 1,778 | 25,974 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | Joseph Loscalzo | Director, Chairman of Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2021 | 1,778 | 9,775 | - | - | Restricted Stock Unit | |
| Ionis Pharma Inc | Joseph Loscalzo | Director, Chairman of Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2021 | 889 | 23,530 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | Joseph Loscalzo | Director, Chairman of Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2021 | 889 | 12,219 | - | - | Restricted Stock Unit | |
| Ionis Pharma Inc | Joseph Loscalzo | Director, Chairman of Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2021 | 666 | 24,196 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | Joseph Loscalzo | Director, Chairman of Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2021 | 666 | 11,553 | - | - | Restricted Stock Unit | |
| Ionis Pharma Inc | Joseph Loscalzo | Director, Chairman of Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 12,000 | 12,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharma Inc | Joseph Loscalzo | Director, Chairman of Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 5,333 | 18,441 | - | - | Restricted Stock Unit |